Stock Market Reviews

SGRY (Surgery Partners, Inc.) News

Get the latest news, insights, and market updates on SGRY (Surgery Partners, Inc.). Explore the news page 3 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• 1 of Wall Street’s Favorite Stock on Our Buy List and 2 That Underwhelm
  The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
  Nov 21, 2025 - $SGRY
• 3 Reasons to Sell SGRY and 1 Stock to Buy Instead
  Surgery Partners has gotten torched over the last six months - since May 2025, its stock price has dropped 35.6% to $15.19 per share. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
  Nov 19, 2025 - $SGRY
• 3 Russell 2000 Stocks with Open Questions
  The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher volatility and risk, as their smaller size makes them more vulnerable to economic downturns.
  Nov 18, 2025 - $SGRY
• 1 Small-Cap Stock for Long-Term Investors and 2 We Avoid
  Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.
  Nov 12, 2025 - $SGRY
• Why Surgery Partners (SGRY) Is Down 26.1% After Lower Q3 Results and Reduced 2025 Revenue Guidance
  On November 10, 2025, Surgery Partners, Inc. reported third-quarter results with revenue of US$821.5 million and a net loss of US$22.7 million, and revised its full-year 2025 revenue guidance down to a range of US$3.275 billion to US$3.30 billion. The company attributed its revised outlook to softer procedure volumes, less favorable payer mix trends, and delays in deploying capital for acquisitions and facility expansion. We’ll explore how Surgery Partners’ lower financial guidance and...
  Nov 11, 2025 - $SGRY
• SGRY Q3 Deep Dive: Guidance Cut Highlights Volume and M&A Timing Pressures
  Healthcare company Surgery Partners (NASDAQ:SGRY) met Wall Streets revenue expectations in Q3 CY2025, with sales up 6.6% year on year to $821.5 million. On the other hand, the company’s full-year revenue guidance of $3.29 billion at the midpoint came in 2% below analysts’ estimates. Its non-GAAP profit of $0.13 per share was 19% below analysts’ consensus estimates.
  Nov 11, 2025 - $SGRY
• Why Surgery Partners Stock Plummeted on Monday
  Investors clearly found much to dislike in the latest earnings report.
  Nov 10, 2025 - $SGRY
• Surgery Partners SGRY Q3 2025 Earnings Transcript
  Eric Evans: Thank you, Dave. Then I will discuss in more detail our recent progress across our three growth pillars: organic growth, margin improvement, and deploying capital for M&A. I'll also provide some additional color on our ongoing strategic portfolio optimization process before concluding with some commentary on our outlook for the remainder of the year. Starting with our organic growth, in our consolidated facilities, we performed over 166,000 surgical cases in the third quarter.
  Nov 10, 2025 - $SGRY
• Why Surgery Partners (SGRY) Stock Is Trading Lower Today
  Shares of healthcare company Surgery Partners (NASDAQ:SGRY) fell 23.8% in the afternoon session after it reported third-quarter results that missed analyst expectations for profit and lowered its full-year 2025 financial forecast.
  Nov 10, 2025 - $SGRY
• Surgery Partners (SGRY) Q3 Earnings and Revenues Lag Estimates
  Surgery Partners (SGRY) delivered earnings and revenue surprises of -31.58% and -0.31%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
  Nov 10, 2025 - $SGRY